Intervacc Competitors and Similar CompaniesClear all
Intervacc's competitors and similar companies include InBios International, Zomedica Pharmaceuticals, Orion and AnimalBiome.
 Intervacc Intervacc is a biotechnology company that engages in research and development of vaccines for animal health. |  InBios International InBios International is a biotech company specializing in the design, development, and manufacture of immunodiagnostic devices for infectious diseases and biothreats. |  Zomedica Pharmaceuticals Zomedica Pharmaceuticals is a veterinary pharmaceutical company targeting health and wellness solutions for companion animals (canine, feline and equine). |  Orion Orion is a company that develops, manufactures, and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients, and diagnostic tests. | ||
Founding Date | Founding Date 1988 | Founding Date 1996 | Founding Date 2015 | Founding Date 1917 | Founding Date 2016 |
Type | Type Public | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations HQ | Locations Seattle, US HQ | Locations Ann Arbor, US HQ Ann Arbor, US | Locations Oakland, US HQ Berkeley, US | |
Employees | Employees N/A | Employees 646% decrease | Employees 284% increase | Employees 3,943 | Employees 594% increase |
Valuation ($) | Valuation ($) 19.9 m | Valuation ($) N/A | Valuation ($) 121 m | Valuation ($) 6.7 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) kr20.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $32m (FY, 2025) | Revenue (est.) €1.9b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods kr31.6m (FY, 2025) | Cost of goods N/A | Cost of goods $10.4m (FY, 2025) | Cost of goods €643.2m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit (kr9.3m) (FY, 2025) | Gross profit N/A | Gross profit $21.7m (FY, 2025) | Gross profit €1.3b (FY, 2025) | Gross profit N/A |
Net income | Net income (kr80.8m) (FY, 2025) | Net income N/A | Net income ($81.9m) (FY, 2025) | Net income €500.3m (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 16m | Total funding raised N/A | Total funding raised $ 2m |
For sources of this data, please see the company profile
View Company Profiles
InBios International
HQ
Seattle, US
Employees
64↓ 6% decrease
InBios International is a biotech company specializing in the design, development, and manufacture of immunodiagnostic devices for infectious diseases and biothreats.
View companyZomedica Pharmaceuticals
HQ
Ann Arbor, US
Employees
28↑ 4% increase
Zomedica Pharmaceuticals is a veterinary pharmaceutical company targeting health and wellness solutions for companion animals (canine, feline and equine).
View companyOrion
HQ
Espoo, FI
Employees
3,943
Orion is a company that develops, manufactures, and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients, and diagnostic tests.
View company
AnimalBiome
HQ
Oakland, US
Employees
59↑ 4% increase
AnimalBiome is a company developing products for pets' gut health.
View company